Ames Seed Capital

VetMeasure, Inc. is a company based in Ames, Iowa, founded in 2015 that specializes in animal health monitoring technology. The company has developed MeasureOn, a wearable harness that enables veterinarians and pet owners to remotely monitor vital health statistics of dogs and other pets. This device tracks parameters such as heart and pulse rates, respiration, body temperature, and ambient conditions, providing real-time data to assess an animal's health status, particularly following surgical procedures or during illness. Utilizing Bluetooth technology and a web application, MeasureOn facilitates accurate health monitoring, enhancing the ability to respond to changes in an animal's condition promptly.

Pitchly, Inc. is a technology company that offers a cloud-based content services platform designed for merger and acquisition professionals. Founded in 2014 and based in Des Moines, Iowa, Pitchly provides a platform that enables users to create and manage custom databases to efficiently organize and activate intellectual property. The platform allows non-technical users to generate data-rich real-time documents in PowerPoint and Word, significantly reducing the time and errors associated with traditional methods of document creation. By aggregating various digital data sources, such as Excel and Salesforce, into a single, normalized view, Pitchly enhances accessibility and usability of information. The service is particularly beneficial for investment banks, accounting and advisory firms, and law firms, as it streamlines the process of locating and integrating relevant data into professional documents and presentations. Additionally, users can create custom forms to ensure that teams access the most current information available.

automed Inc designs and manufactures automatic livestock medication systems. It offers automed, an automatic livestock medication systems that automatically calculates, delivers, and record livestock treatments, and help livestock producers manage their operation; and automed adapters that allow user to administer medication through injection, drench, pour-on and intra-nasal automatically, accurately, and efficiently. The company was founded in 2012 and is based in Belconnen, Australia.

FindBob is a transition management platform tailored for financial advisors and insurance agents. It employs machine learning and gamification techniques to enhance asset protection and facilitate growth-oriented transitions within the financial services industry. The platform streamlines the process of advisor transitions, enabling firms to discover new opportunities while ensuring internal adjustments are made safely. By focusing on asset protection and talent retention, FindBob helps firms generate new revenue streams and maintain advisor practices that adhere to fiduciary standards. Its comprehensive approach supports financial advisors in navigating transitions effectively, ultimately fostering a culture of growth and stability within the industry.

NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology products to improve the lives of patients with cancer. Founded more than 15 years ago, NewLink Genetics continues to be at the forefront in immuno-oncology treatments led by a diverse group of industry professionals and physician-scientists. Personal cancer stories inspire their relentless research and development in advancing treatments. Their mission is to change the cancer treatment paradigm and make a difference in patient lives every day.

NewLink Genetics is a biopharmaceutical company focused on discovering, developing, and commercializing novel immuno-oncology products to improve the lives of patients with cancer. Founded more than 15 years ago, NewLink Genetics continues to be at the forefront in immuno-oncology treatments led by a diverse group of industry professionals and physician-scientists. Personal cancer stories inspire their relentless research and development in advancing treatments. Their mission is to change the cancer treatment paradigm and make a difference in patient lives every day.